Pharmafile Logo
Pharmafocus logo
Advanced Search
brain-770044_960_720

Lilly’s drug for early Alzheimer’s shows promising results

August 6, 2025
Medical Communications, Research and Development Alzheimer's, Eli Lilly, Neurology, dementia

Eli Lilly (Lilly) has announced positive new data from the long-term extension of its phase 3 study, showing that Kisunla …

News
blood-1813410_960_720

FDA grants orphan drug designation to relapsed or refractory multiple myeloma candidate

August 6, 2025
Medical Communications, Research and Development Oncology, Sanofi, US Food and Drug Administration, myeloma

The US Food and Drug Administration (FDA) has granted orphan drug designation to SAR446523, Sanofi’s investigational monoclonal antibody developed for …

News

Polpharma Biologics and Fresenius Kabi partner to develop treatment for ulcerative colitis and Crohn’s disease

August 5, 2025
Mergers and Acquisitions Corporate, Crohn’s disease, Fresenius Kabi, Gastrointestinal tract, Polpharma Biologics, ulcerative colitis

Polpharma Biologics has signed a global licensing agreement with Fresenius Kabi for the commercialisation of PB016, a proposed biosimilar to …

News

Freya Pharma launches phase 2 study of therapy for female sexual dysfunction

August 5, 2025
Research and Development Female Sexual Interest/Arousal Disorder (FSIAD), Freya Pharma Solutions, Genito-Urinary system, sexual health

Freya Pharma Solutions has announced the initiation of a phase 2 study evaluating its Lybrido to treat female sexual interest/arousal …

News

Advarra appoints Brian Hart as chief technology officer

August 5, 2025
Business Services, Technical Consultancy Advarra, Corporate, chief technology officer, digital solutions

Digital solutions company, Advarra, has named Brian Hart as chief technology officer, strengthening its leadership team. Hart brings more than …

Appointment

Hansa Biopharma announces positive data for Duchenne muscular dystrophy gene therapy

August 4, 2025
Research and Development Duchenne Muscular Dystophy, Hansa Biopharma, Rare Diseases, Sarepta Therapeutics, clinical trial, genetic disorder

Hansa Biopharma has announced encouraging results from its ongoing SRP-9001-104 trial, which is investigating the use of imlifidase as a …

News
office-space-1988480_960_720

Biocair expands globally with new Shanghai office

August 4, 2025
Logistics & Distribution, Manufacturing and Production Biocair, Corporate, life sciences logistics

Life science logistics specialist, Biocair, has announced the opening of a new office in Shanghai, marking a significant expansion of …

News
nerve-cell-2213009_960_720

Central nervous system cancer metastases – the evolution of diagnostics and treatment

August 4, 2025
CERo therapeutics, Cancer, T cell, immunotherapy

The current forms of immunotherapy, how T cell therapy works and what the future holds

Feature

Five Facts about sleep and mental health

August 3, 2025
Medical Communications Five Facts, Psychiatry, insomnia, mental health, sleep, sleep disorders, sleep health

1 Rapid Eye Movement (REM) sleep enhances creative thinking and helps the brain form connections between ideas, supporting mental wellbeing …

Feature

The Pharma Files: With Priyanka Hinton from CHASE

August 3, 2025
Business Services, Recruitment CHASE, The Pharma Files

Pharmafile chats with Priyanka Hinton, Customer Solutions Director at Chase People about the best parts of her job and her …

Feature

A challenge we can no longer ignore: meeting the needs of people with Crohn’s Disease in the UK

August 3, 2025
Research and Development Crohn’s disease, Immunology, Lilly UK, autoimmune disease, immunology

By Holly Thomas, Associate Vice-President Specialty Care at Lilly UK and Ireland Immunology care in the UK is at a …

Feature

Ryvu Therapeutics publishes research revealing potential drug combination for colorectal cancer

August 1, 2025
Medical Communications, Research and Development Oncology, Ryvu Therapeutics, colorectal cancer

Ryvu Therapeutics has published new findings from its ONCO Prime target discovery platform in Scientific Reports. The study reveals a …

News

ESTEVE expands into US market with acquisition of Regis Technologies

August 1, 2025
Mergers and Acquisitions Corporate, ESTEVE, Pharmacy, Regis Technologies, US pharma market, contract development and manufacturing organisation

ESTEVE (Esteve Química), based in Barcelona, Spain, has acquired Regis Technologies, a contract development and manufacturing organisation (CDMO) based in …

News

Richmond Pharmacology appoints Priscilla Ochuba as associate medical director

August 1, 2025
Research and Development Contract Research Organsation, Corporate, Pharmacy, Richmond Pharmacology, associate medical director

Richmond Pharmacology has announced the promotion of Priscilla Ochuba to associate medical director, effective 1 August 2025. The move recognises …

Appointment

Labguru and Titian Software rebrand as Cenevo to accelerate connected labs

July 31, 2025
Analytical & Laboratory Services, Research and Development Cenevo, Corporate, Labguru, Laboratory management

Lab management companies, Labguru and Titian Software, have rebranded under a new unified name, Cenevo. This combines their solutions, Mosaic …

News
lab

Hansa Biopharma bolsters leadership team with new executive appointments

July 31, 2025
Research and Development Chief Human Resources Officer, Chief Legal Officer, Corporate, Executive Leadership Team, Hansa Biopharma, Vice President Corporate Affairs

Hansa Biopharma has announced three senior leadership appointments to support its global expansion as well as pre-commercial activities in the …

Appointment

BioDuro and Atombeat partner to accelerate AI-powered peptide drug discovery

July 31, 2025
Mergers and Acquisitions AI, BioDuro, Corporate, Devices

BioDuro and Atombeat have announced a partnership to launch an artificial intelligence (AI)-driven platform designed to accelerate peptide drug discovery …

News

Key strategies to foster digital transformation in the NHS

July 30, 2025
Business Services, Market Access, Market Access Consultancy Corporate, Gateway to Local Adoption, NHS, Pharmacy, Visions4Health, digital transformation, pharmacy

In the third of the Gateway to Local Adoption series, Visions4Health caught up with James Scott, Digital and Informatics Specialist …

Feature

NICE approves AstraZeneca’s dual immunotherapy for advanced liver cancer

July 30, 2025
Medical Communications, Research and Development AstraZeneca, NHS, National Institute for Health and Care Excellence, Oncology, dual immunotherapy, hepatocellular carcinoma, liver cancer

AstraZeneca has received a positive recommendation from the National Institute for Health and Care Excellence (NICE) for its dual immunotherapy …

News
laboratory-testing-az

Clinisys acquires Orchard Software to expand laboratory informatics leadership

July 30, 2025
Analytical & Laboratory Services, Mergers and Acquisitions, Research and Development Clinisys, Corporate, Francisco Partners, Orchard Software, laboratory informatics, laboratory information management systems

Clinisys has announced the acquisition of Orchard Software from Francisco Partners, strengthening its position in laboratory informatics. The strategic acquisition …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025